Published in Helv Med Acta Suppl on June 01, 1970
[Pharmacokinetics of midazolam after i.v. administration (author's transl)]. Arzneimittelforschung (1981) 1.58
T-lymphocytosis in bronchoalveolar lavage fluid of hypersensitivity pneumonitis. Changes in profile of T-cell subsets during the course of disease. Chest (1984) 1.50
Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. Am Rev Respir Dis (1990) 1.47
Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. Clin Exp Allergy (2001) 1.45
Ia-like antigens on T-cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis. Analysis of bronchoalveolar and blood lymphocytes. Am Rev Respir Dis (1985) 1.42
[Guidelines to long-term oxygen therapy]. Pneumologie (2001) 1.41
Satuation exposures at 31 ATA in an oxygen-helium atmosphere with excursions to 36 ATA. Aerosp Med (1970) 1.39
[Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study]. Pneumologie (1999) 1.38
T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med (1995) 1.29
Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts. Eur Respir J (1996) 1.21
Bioavailability from various galenic formulations of flunitrazepam. Arzneimittelforschung (1977) 1.19
[New theoretical values in exploration of the respiratory function of the lung]. Bull Physiopathol Respir (Nancy) (1972) 1.17
Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br J Psychiatry (1996) 1.15
Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol (2000) 1.13
New method for easy labeling of beta-2-agonists in the metered dose inhaler with technetium 99m. Respiration (1988) 1.11
Pharmacokinetic and clinical considerations in the choice of a hypnotic. Br J Clin Pharmacol (1983) 1.09
[Adhesion receptors: pathophysiologic, diagnostic and therapeutic importance]. Med Klin (Munich) (1993) 1.07
Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibroses. Eur J Respir Dis Suppl (1986) 1.06
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol (2003) 1.04
Alterations in immunoregulatory T-cell subsets in cigarette smokers. A phenotypic analysis of bronchoalveolar and blood lymphocytes. Chest (1986) 1.04
Predictive value of bronchoalveolar T cell subsets for the course of pulmonary sarcoidosis. Ann N Y Acad Sci (1986) 1.03
[Relationship between clinical effects and pharmacokinetics of midazolam on i.m. and i.v. application to volunteers/1st comm.: Clinical aspects (author's transl)]. Arzneimittelforschung (1981) 1.01
Symbols, abbreviations and units. Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl (1993) 1.00
Pharmacokinetic and clinical observations on prolonged administration of flunitrazepam. Eur J Clin Pharmacol (1980) 0.99
Dextromethorphan and codeine: objective assessment of antitussive activity in patients with chronic cough. J Int Med Res (1983) 0.98
Mechanism of membrane damage mediated by eosinophil major basic protein. Lancet (1987) 0.98
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. Eur J Cardiol (1979) 0.97
Inflammatory determinants of asthma severity: mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma. J Allergy Clin Immunol (1996) 0.96
Mucociliary clearance in smokers. Eur J Respir Dis (1986) 0.95
Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states. J Neural Transm Suppl (1989) 0.93
Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-alpha on eosinophil activation in vitro. Am J Respir Cell Mol Biol (1999) 0.93
Pharmacology of flumazenil. Acta Anaesthesiol Scand Suppl (1995) 0.93
Increase in perforin-positive peripheral blood lymphocytes in extrinsic and intrinsic asthma. Am J Respir Crit Care Med (2000) 0.92
Comparative measurements of airway resistance. Respiration (1975) 0.92
Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. Br J Psychiatry (1992) 0.91
Lung and blood lymphocyte subsets in asbestosis and in mixed dust pneumoconiosis. Chest (1987) 0.91
The pattern of flow in the upper human airways. Respir Physiol (1968) 0.89
[Pharmacokinetics of soporific drugs]. ZFA (Stuttgart) (1980) 0.89
Evaluation of the efficacy and tolerance of orally administered midazolam as hypnotic agent compared with oxazepam in the treatment of insomnia of mild to moderate severity. Arzneimittelforschung (1981) 0.89
Effects of interferon-gamma and tumour necrosis factor-alpha on CD95/Fas ligand-mediated apoptosis in human blood eosinophils. Scand J Immunol (2000) 0.88
Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects. Psychopharmacology (Berl) (1998) 0.87
Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part II). Eur Respir J (1994) 0.86
Moclobemide and tricyclic antidepressants in severe depression: meta-analysis and prospective studies. J Clin Psychopharmacol (1995) 0.86
[The influence of beta-adrenergic stimulation on the mucociliary system of the human lung (author's transl)]. Pneumonologie (1975) 0.86
[Cytologic and immunocytologic findings in bronchoalveolar lavage as a contribution to the differential diagnosis of chronic lung hemorrhage]. Pneumologie (1990) 0.86
Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J Immunol (1996) 0.86
Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group. Int Clin Psychopharmacol (1997) 0.86
Bone mineral density and quantitative ultrasound in adults with cystic fibrosis. Eur J Endocrinol (2002) 0.85
CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma. Eur Respir J (1998) 0.85
Prostacyclin modulates granulocyte/macrophage colony-stimulating factor release by human blood mononuclear cells. Pulm Pharmacol (1996) 0.85
[A new biopsy needle for transcutaneous histology procurement]. Schweiz Med Wochenschr (1987) 0.85
[Aerosol therapy]. Prax Klin Pneumol (1988) 0.84
[Comparison of the antitussive effect of two different drugs regarding frequency and strength of cough attacks (author's transl)]. Med Klin (1977) 0.84
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. Braz J Med Biol Res (2011) 0.84
The antihypertensive effect of lexotan (bromazepam)- a new benzodiazepine derivative. Int J Clin Pharmacol Biopharm (1977) 0.84
Bronchoalveolar lavage cell data in alveolar proteinosis. Am Rev Respir Dis (1991) 0.84
[Physical training of patients with sleep apnea]. Pneumologie (1997) 0.84
[New normal values for the pulmonary function test with whole body plethysmography]. Dtsch Med Wochenschr (1969) 0.84
Pulmonary deposition of aerosols by different mechanical devices. Respiration (1985) 0.84
The immunoperoxidase slide assay. A new method for the demonstration of surface antigens on bronchoalveolar lavage cells. Bull Eur Physiopathol Respir (1985) 0.83
Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils. Eur J Immunol (1998) 0.83
Normocapnia during nIPPV in chronic hypercapnic COPD reduces subsequent spontaneous PaCO2. Respir Med (2002) 0.83
Mucociliary clearance in patients with chronic bronchitis and bronchial carcinoma. Respiration (1983) 0.82
Effects of TGF-beta on eosinophil chemotaxis. Scand J Immunol (1998) 0.82
Postvitrectomy positioning complicated by ulnar nerve palsy. Am J Ophthalmol (1996) 0.82
[Epidemiology and costs of bronchial asthma and chronic bronchitis in Germany]. Dtsch Med Wochenschr (2001) 0.82
Ca(2+)-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor. Proc Natl Acad Sci U S A (1991) 0.81
CD69 surface expression on human lung eosinophils after segmental allergen provocation. Eur Respir J (1999) 0.81
Differential modulation of interleukin-4 and interleukin-13 secretion from human peripheral blood mononuclear cells. Immunol Lett (1999) 0.80
[Critical selection of normal values for a computer program in the evaluation of lung function (author's transl)]. Pneumonologie (1976) 0.80
Social phobia: long-term treatment outcome and prediction of response--a moclobemide study. Int Clin Psychopharmacol (1997) 0.80
Interferon-gamma secretion of peripheral blood CD8+ T lymphocytes in patients with bronchial asthma: in vitro stimulus determines cytokine production. Clin Exp Immunol (2001) 0.80
[Methodologic study for measuring oronasal airflow using thermistors]. Pneumologie (1989) 0.80
[Additive action of theophylline and ambroxol on bronchial clearance?]. Prax Klin Pneumol (1988) 0.80
Assessment of pharmacodynamics of a new "controlled release" form of diazepam (Valium CR Roche) by quantitative EEG and psychometric analysis in neurotic subjects. J Int Med Res (1981) 0.79
Inhibition of HLA-DR expression on activated human blood eosinophils by transforming growth factor-beta1. Scand J Immunol (1998) 0.79
Modulatory role of protein kinase C on the signal transduction pathway utilized by platelet-activating factor in eosinophil activation. Am J Respir Cell Mol Biol (1994) 0.79
Modulation of cytokine release from mononuclear cells by prostacyclin, IL-4 and IL-13. Cytokine (1999) 0.79
[Effect of celiprolol, fenoterol and aminophylline on respiratory tract obstruction during an asthma attack]. Schweiz Med Wochenschr (1982) 0.79
Pulmonary sarcoidosis: assessment of disease activity by lung lymphocyte subpopulations. Klin Wochenschr (1983) 0.79
HLA-DR antigens on human macrophages from bronchoalveolar lavage fluid. Thorax (1986) 0.79
Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics. Immunology (1993) 0.79
Antiasthma drug delivery. What is on the horizon? Clin Pharmacokinet (1994) 0.79
Analysis of forced expired volume signals using multi-exponential functions. Med Biol Eng Comput (2001) 0.79
Mucociliary clearance and airways obstruction in smokers, ex-smokers and normal subjects who never smoked. Eur J Respir Dis Suppl (1985) 0.79
Effect of theophylline on mucociliary clearance in man. Eur J Respir Dis Suppl (1980) 0.78
Morphology and density features of eosinophil leukocytes in eosinophilic pneumonia. A case report. Clin Investig (1992) 0.78
Diagnosis by bronchoalveolar lavage of cause of pulmonary infiltrates in haematological malignancies. Br Med J (Clin Res Ed) (1985) 0.78
Comparison of sputum-ECP levels in bronchial asthma and chronic bronchitis. Allergy (1993) 0.78
[Epidemiology and costs of lung cancer in Germany]. Pneumologie (2001) 0.78
Cytokines, platelet activating factor and eosinophils in asthma. Respir Med (1992) 0.78
[New normal values in exploration of pulmonary function by body plethysmography]. J Fr Med Chir Thorac (1970) 0.78
The therapeutic value of clonidine in patients with coronary heart disease. Eur J Cardiol (1979) 0.78
Multinucleated cells in bronchoalveolar lavage. Acta Cytol (1985) 0.78
Antidepressants and drug-metabolizing enzymes--expert group report. Acta Psychiatr Scand (1996) 0.78
Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients. J Cardiovasc Pharmacol (1986) 0.78
Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder. Int Clin Psychopharmacol (2002) 0.77
Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3--a new tumor marker. Lung (1995) 0.77
[Comparison of cardiac output at rest and during physical exertion using thermodilution and Fick's principle]. Schweiz Med Wochenschr (1973) 0.77